UnitedHealth Group Inc (UNH) Shares Bought by D.A. Davidson & CO.

D.A. Davidson & CO. grew its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.5% during the third quarter, according to its most recent filing with the SEC. The firm owned 72,007 shares of the healthcare conglomerate’s stock after acquiring an additional 1,749 shares during the period. D.A. Davidson & CO.’s holdings in UnitedHealth Group were worth $14,102,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of UNH. Jennison Associates LLC grew its stake in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after buying an additional 3,289,470 shares during the last quarter. Janus Henderson Group PLC lifted its position in UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. lifted its position in UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. Parametric Portfolio Associates LLC lifted its position in UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after acquiring an additional 1,562,661 shares in the last quarter. Finally, Thrivent Financial For Lutherans lifted its position in UnitedHealth Group by 346.7% in the 2nd quarter. Thrivent Financial For Lutherans now owns 1,690,187 shares of the healthcare conglomerate’s stock valued at $313,394,000 after acquiring an additional 1,311,773 shares in the last quarter. Hedge funds and other institutional investors own 86.00% of the company’s stock.

In related news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of the firm’s stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the completion of the transaction, the director now directly owns 76,637 shares in the company, valued at $18,881,824.06. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 53,396 shares of company stock worth $12,262,067. 0.89% of the stock is owned by insiders.

UnitedHealth Group Inc (NYSE UNH) traded up $2.14 during midday trading on Wednesday, hitting $228.78. The stock had a trading volume of 2,871,040 shares, compared to its average volume of 4,300,000. The company has a market cap of $221,700.00, a PE ratio of 24.08, a price-to-earnings-growth ratio of 1.32 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group Inc has a 12-month low of $156.49 and a 12-month high of $250.79.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same period last year, the firm earned $2.11 EPS. UnitedHealth Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. UnitedHealth Group’s dividend payout ratio is currently 31.58%.

Several equities analysts recently issued reports on the company. Oppenheimer upped their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research report on Wednesday, October 18th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Morgan Stanley upped their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. Leerink Swann reaffirmed a “buy” rating and issued a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Finally, Argus upped their price objective on UnitedHealth Group from $215.00 to $230.00 and gave the company a “buy” rating in a research report on Thursday, October 19th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $243.22.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Shares Bought by D.A. Davidson & CO.” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/14/unitedhealth-group-inc-unh-shares-bought-by-d-a-davidson-co-2.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply